Monthly Communication Report

Organization:	Amyotrophic Lateral Sclerosis Society of Canada/Société Canadienne de la Sclérose Latérale Amyotrophique
Associated registration:	895134-16791-38
Communication date:	2026-04-16
Posted date:	2026-04-21

Designated Public Office Holders who participated in the communication:	Peter Fragiskatos, Member of Parliament House of Commons
List of Details Subject matter Detail Budget, Defence, Economic Development, Health, Industry, Research and Development, Science and Technology, Taxation and Finance To provide funding for the Canadian Collaboration to Cure ALS, to establish a coordinated national research ecosystem through which every Canadian living with ALS can participate in, and benefit from, cutting-edge science that will accelerate discoveries by Canadian researchers, advance understanding of the disease, and enable the development of therapies to treat this devastating terminal illness with greater precision. Sources of funding are to be determined.
Responsible Officer who filed this communication report:	Tammy Moore
As the most senior paid officer, the person named above is responsible for certifying the communication report for the corporation or organization (Registrant). This person may or may not have participated in the reported communication. The Lobbyists Registration Regulations do not require that the names of in-house lobbyists (i.e. employees of corporations or organizations) who actually participated in the communication be disclosed.